Sapu Nano completes Phase 1b safety cohort, gets dose escalation nod
July 13, 2026 | 10:00
Sapu Nano completed the initial safety cohort of its Phase 1b SP-03-B101 trial, with an independent Safety Review Committee recommending dose escalation and European expansion for the nanomedicine platform.
Mobile Version